HIV trials recruiting in Tennessee

All HIV trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · Tennessee: Memphis, Nashville
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Tennessee: Nashville
• A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
  NCT07390955 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Tennessee: Nashville
• A Study to Improve Skeletal Muscle in Veterans With HIV
  NCT06845046 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 80 Years · Sex: Male · Tennessee: Nashville
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Tennessee: Nashville
• GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
  NCT07221214 · Phase: Phase 2 · Ages: 18 Years to 89 Years · Sex: All (male and female) · Tennessee: Nashville
• Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
  NCT05288790 · Phase: Phase 2 · Ages: 18 Years to 89 Years · Sex: All (male and female) · Tennessee: Nashville
• Positive Peers Intervention Clinical Trial
  NCT06388109 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 34 Years · Sex: All (male and female) · Tennessee: Memphis
• Providing Access to the Visual Environment
  NCT00341744 · Phase: Not specified · Ages: 3 Years to 21 Years · Sex: All (male and female) · Tennessee: Nashville
• Screen2Prevent (S2P)
  NCT07728123 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 24 Years · Sex: All (male and female) · Tennessee: Memphis
• Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
  NCT07293559 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Tennessee: Memphis
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · Tennessee: Memphis